{
    "organizations": [],
    "uuid": "ef04cf7530984dd61fecd5900017c5a99aed54da",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/idUSL5N1RH50L",
    "ord_in_thread": 0,
    "title": "BRIEF-OncoArendi Therapeutics Allots 2 Mln Shares At 29 Zlotys/Shr",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 4 (Reuters) - ONCOARENDI THERAPEUTICS SA ( IPO-ORT.WA ):\n* SAYS IT ALLOCATED 2 MILLION SERIES F SHARES, SO THAT 140,000 OF OFFERED SHARES WERE ALLOTTED TO INDIVIDUAL INVESTORS AND 1,860,000 OF SHARES WERE ALLOTTED TO INSTITUTIONAL INVESTORS\n* INDIVIDUAL INVESTORS SUBSCRIBED FOR 276,916 SHARES, SO THIS ALLOTMENT OF SHARES HAD AVERAGE REDUCTION RATE OF 49.44%\n* ISSUE PRICE FOR COMPANYâ€™S SHARES IN IPO WAS SET AT 29 ZLOTYS PER SHARE\nFurther company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-04T23:51:00.000+03:00",
    "crawled": "2018-04-05T17:20:15.025+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "oncoarendi",
        "therapeutic",
        "sa",
        "say",
        "allocated",
        "million",
        "series",
        "f",
        "share",
        "offered",
        "share",
        "allotted",
        "individual",
        "investor",
        "share",
        "allotted",
        "institutional",
        "investor",
        "individual",
        "investor",
        "subscribed",
        "share",
        "allotment",
        "share",
        "average",
        "reduction",
        "rate",
        "issue",
        "price",
        "company",
        "share",
        "ipo",
        "set",
        "zloty",
        "per",
        "share",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}